Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2840993rdf:typepubmed:Citationlld:pubmed
pubmed-article:2840993lifeskim:mentionsumls-concept:C0085979lld:lifeskim
pubmed-article:2840993lifeskim:mentionsumls-concept:C0029923lld:lifeskim
pubmed-article:2840993lifeskim:mentionsumls-concept:C0234421lld:lifeskim
pubmed-article:2840993lifeskim:mentionsumls-concept:C0458827lld:lifeskim
pubmed-article:2840993lifeskim:mentionsumls-concept:C0004048lld:lifeskim
pubmed-article:2840993lifeskim:mentionsumls-concept:C0021467lld:lifeskim
pubmed-article:2840993lifeskim:mentionsumls-concept:C0886658lld:lifeskim
pubmed-article:2840993lifeskim:mentionsumls-concept:C0079043lld:lifeskim
pubmed-article:2840993lifeskim:mentionsumls-concept:C1444748lld:lifeskim
pubmed-article:2840993lifeskim:mentionsumls-concept:C0205390lld:lifeskim
pubmed-article:2840993lifeskim:mentionsumls-concept:C0021469lld:lifeskim
pubmed-article:2840993lifeskim:mentionsumls-concept:C1516369lld:lifeskim
pubmed-article:2840993lifeskim:mentionsumls-concept:C0205087lld:lifeskim
pubmed-article:2840993pubmed:issue1lld:pubmed
pubmed-article:2840993pubmed:dateCreated1988-9-12lld:pubmed
pubmed-article:2840993pubmed:abstractTextBronchial challenge of ovalbumin-sensitized conscious guinea-pigs induced a triphasic reduction in specific airways conductance (sGaw) with maximal reductions being observed at 2, 17 and 72 h accompanied by infiltration of the airways with neutrophils at 17 h and eosinophils at 17 and 72 h. Nedocromil sodium (10 mg ml-1) inhaled before challenge blocked the 2 and 17 h sGaw response and the neutrophil influx. When inhaled 6 h after challenge, nedocromil inhibited the 17 h sGaw response but not neutrophil influx, suggesting that these are unrelated. The sGaw response and eosinophil accumulation at 72 h was also inhibited by nedocromil given at this time. Our findings correlate with the clinical effects of nedocromil, suggesting the guinea-pig model may be useful for investigating the mechanism of action of anti-asthmatic drugs.lld:pubmed
pubmed-article:2840993pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2840993pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2840993pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2840993pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2840993pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2840993pubmed:languageenglld:pubmed
pubmed-article:2840993pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2840993pubmed:citationSubsetIMlld:pubmed
pubmed-article:2840993pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2840993pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2840993pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2840993pubmed:statusMEDLINElld:pubmed
pubmed-article:2840993pubmed:monthMaylld:pubmed
pubmed-article:2840993pubmed:issn0007-1188lld:pubmed
pubmed-article:2840993pubmed:authorpubmed-author:HolgateS TSTlld:pubmed
pubmed-article:2840993pubmed:authorpubmed-author:ChurchM KMKlld:pubmed
pubmed-article:2840993pubmed:authorpubmed-author:HutsonP APAlld:pubmed
pubmed-article:2840993pubmed:issnTypePrintlld:pubmed
pubmed-article:2840993pubmed:volume94lld:pubmed
pubmed-article:2840993pubmed:ownerNLMlld:pubmed
pubmed-article:2840993pubmed:authorsCompleteYlld:pubmed
pubmed-article:2840993pubmed:pagination6-8lld:pubmed
pubmed-article:2840993pubmed:dateRevised2010-11-18lld:pubmed
pubmed-article:2840993pubmed:meshHeadingpubmed-meshheading:2840993-...lld:pubmed
pubmed-article:2840993pubmed:meshHeadingpubmed-meshheading:2840993-...lld:pubmed
pubmed-article:2840993pubmed:meshHeadingpubmed-meshheading:2840993-...lld:pubmed
pubmed-article:2840993pubmed:meshHeadingpubmed-meshheading:2840993-...lld:pubmed
pubmed-article:2840993pubmed:meshHeadingpubmed-meshheading:2840993-...lld:pubmed
pubmed-article:2840993pubmed:meshHeadingpubmed-meshheading:2840993-...lld:pubmed
pubmed-article:2840993pubmed:meshHeadingpubmed-meshheading:2840993-...lld:pubmed
pubmed-article:2840993pubmed:meshHeadingpubmed-meshheading:2840993-...lld:pubmed
pubmed-article:2840993pubmed:meshHeadingpubmed-meshheading:2840993-...lld:pubmed
pubmed-article:2840993pubmed:meshHeadingpubmed-meshheading:2840993-...lld:pubmed
pubmed-article:2840993pubmed:meshHeadingpubmed-meshheading:2840993-...lld:pubmed
pubmed-article:2840993pubmed:year1988lld:pubmed
pubmed-article:2840993pubmed:articleTitleInhibition by nedocromil sodium of early and late phase bronchoconstriction and airway cellular infiltration provoked by ovalbumin inhalation in conscious sensitized guinea-pigs.lld:pubmed
pubmed-article:2840993pubmed:affiliationImmunopharmacology Group, Southampton General Hospital.lld:pubmed
pubmed-article:2840993pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2840993pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2840993lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2840993lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2840993lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2840993lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2840993lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2840993lld:pubmed